Cite
HARVARD Citation
Branch-Elliman, W. et al. (n.d.). 517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial. Open forum infectious diseases. p. S360. [Online].